Vascular access and contrast media.

Over the past several years, the Food and Drug Administration (FDA) has received more than 250 adverse event reports in which vascular access devices have ruptured when used with power injectors. The adverse events include rupture and device fragmentation. The outcome of these events affects both the patient and the care provider.

Assessing pediatric patients for vascular access and sedation.

Central venous catheters have been established as a reliable source of vascular access since the 1970s. Peripherally inserted central catheters became a popular central catheter in the early 1990s for adults and children. The management of vascular access in children is an essential part of inpatient and outpatient care.

Diagnostic tools and therapeutic interventions that may influence the integrity of vascular and nonvascular access devices.

Current technology introduces many new vascular and nonvascular devices to the medical field. With the assistance of these devices, patients can be offered many more diagnostic tests and therapeutic treatments that aid in the diagnosis and treatment of diseases. As with any new infusion technology, these devices can be associated with complications attributable to the rapid rate of infusion.